The performance of companies tied to blockbuster drugs like Viagra presents a nuanced investment landscape . While the initial surge of copyright, fueled by Viagra's remarkable popularity, generated substantial wealth , the loss of exclusivity in key regions has introduced considerable volatility. Investors are now grappling with the impact of gene